✈️New Airworthiness Directive Proposed for Boeing 787 Models
The FAA proposes to adopt a new airworthiness directive (AD) for certain The Boeing Company Model 787-8, 787-9, and 787-10 airplanes. This proposed AD was prompted by a report of multiple instances of loss of transponder for airplanes entering airspace in the presence of continuous wave (CW) interference, where the transponder did not meet the minimum operational performance standards (MOPS) requirement for transponder response. This proposed AD would require replacing the left and right integrated surveillance system processor unit (ISSPU) hardware. The FAA is proposing this AD to address the unsafe condition on these products.
Learn More🏡Proposed Information Collection for HUD Loan Guarantee Programs
HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comment from all interested parties on the proposed collection of information. The purpose of this notice is to allow for 60 days of public comment.
Learn More🦠FDA Classifies Antimicrobial Susceptibility Testing Device as Class II
The Food and Drug Administration (FDA, the Agency, or we) is classifying the cellular analysis system for multiplexed antimicrobial susceptibility testing into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the cellular analysis system for multiplexed antimicrobial susceptibility testing's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More💻FDA Final Order on Radiological Computer-Assisted Detection Devices
The Food and Drug Administration (FDA, the Agency, or we) is classifying the radiological computer-assisted detection and diagnosis software into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the radiological computer-assisted detection and diagnosis software's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More💵CPSC Proposed Carbon Monoxide Grant Program Information
As required by the Paperwork Reduction Act of 1995, the Consumer Product Safety Commission (CPSC or Commission) announces that the Commission has submitted to the Office of Management and Budget (OMB) a request for approval of a new information collection. The collection is for an application by which potential grant recipients may request funding under CPSC's Carbon Monoxide Poisoning Prevention Grant Program (COPPGP). The COPPGP provides funds for state, local and tribal governments to reduce the number of injuries and deaths from carbon monoxide poisoning. On March 11, 2025, CPSC published a notice in the Federal Register to announce the agency's intention to seek approval of the collection of information. The Commission received one comment in support of the collection. By publication of this notice, the Commission announces that CPSC has submitted to the OMB a request for that collection of information.
Learn More🍈Ripe Olives From Spain
The U.S. Department of Commerce (Commerce) determines that certain exporters/producers of ripe olives from Spain received countervailable subsidies during the period of review (POR) January 1, 2022, through December 31, 2022.
Learn More❌Notice of Cancellation for NIH Meeting on K99/R00 Applications
The Department of Health and Human Services announces the cancellation of a meeting regarding the review of K99/R00 applications originally scheduled for July 2025. This meeting has been shifted from the National Institute of General Medical Sciences to the Center for Scientific Review, highlighting an organizational change within the NIH that may affect future research funding processes.
Learn More⚖️DEA Revocation of Registration for James F. Brown, D.P.M.
The Department of Justice's Drug Enforcement Administration issued a Decision and Order revoking James F. Brown’s DEA registration due to material falsification on his application and lack of authority in California. The case highlights the critical importance of accurate disclosures in licensing and compliance within the healthcare sector.
Learn More💊FDA Requests Comments for Rare Disease Innovation Workshop Series
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following request for comments for a future public workshop series entitled "Rare disease Innovation, Science, and Exploration (RISE) Workshop." The purpose of the public workshops will be to focus on challenges that are common to multiple diseases or a class of diseases, and for which evolving science offers innovative solutions. The workshops will primarily focus on cross-cutting or common issues and will not be focused on any specific product under review by the Agency.
Learn More⚙️Final Results on Countervailing Duties for Steel Flanges from India
The U.S. Department of Commerce (Commerce) determines that certain producers and/or exporters of finished carbon steel flanges (steel flanges) from India received countervailable subsidies during the period of review (POR) January 1, 2022, through December 31, 2022. In addition, Commerce is rescinding this review, in part, with respect to 30 companies.
Learn More